Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia
This study has been completed.
Information provided by:
First received: September 23, 2004
Last updated: January 21, 2010
Last verified: January 2010
The purpose of this study is to assess the cholesterol lowering safety and effectiveness of two investigational drugs in patients with mixed hyperlipidemia (high cholesterol and high triglycerides).
Drug: MK0653, ezetimibe
Drug: Comparator: fenofibrate monotherapy
|Study Design:||Endpoint Classification: Safety/Efficacy Study
Primary Purpose: Treatment
|Official Title:||Evaluation of the Efficacy and Safety of Fenofibrate and Ezetimibe Coadministration in Patients With Mixed Hyperlipidemia|
Resource links provided by NLM:
Genetics Home Reference related topics: Chanarin-Dorfman syndrome cholesteryl ester storage disease Farber lipogranulomatosisU.S. FDA Resources
Further study details as provided by Merck:
Contacts and Locations